The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
|
---|---|
Published in |
Frontiers in Pharmacology, November 2021
|
DOI | 10.3389/fphar.2021.758763 |
Pubmed ID | |
Authors |
Yinan Shi, Chenxin Gu, Tongtong Zhao, Yangfan Jia, Changlei Bao, Ang Luo, Qiang Guo, Ying Han, Jian Wang, Stephen M. Black, Ankit A. Desai, Haiyang Tang |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 17% |
Unknown | 10 | 83% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 12 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 11 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 4 | 36% |
Student > Doctoral Student | 1 | 9% |
Student > Ph. D. Student | 1 | 9% |
Student > Master | 1 | 9% |
Researcher | 1 | 9% |
Other | 1 | 9% |
Unknown | 2 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 4 | 36% |
Biochemistry, Genetics and Molecular Biology | 2 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 9% |
Nursing and Health Professions | 1 | 9% |
Medicine and Dentistry | 1 | 9% |
Other | 0 | 0% |
Unknown | 2 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2021.
All research outputs
#5,721,726
of 23,310,485 outputs
Outputs from Frontiers in Pharmacology
#2,297
of 16,763 outputs
Outputs of similar age
#112,181
of 436,215 outputs
Outputs of similar age from Frontiers in Pharmacology
#167
of 1,145 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,763 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,215 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 1,145 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.